G Calandra

Summary

Affiliation: AnorMED Inc
Country: Canada

Publications

  1. ncbi AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
    G Calandra
    AnorMED Corp of Genzyme Corp, Langley, British Columbia, Canada
    Bone Marrow Transplant 41:331-8. 2008

Collaborators

Detail Information

Publications1

  1. ncbi AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
    G Calandra
    AnorMED Corp of Genzyme Corp, Langley, British Columbia, Canada
    Bone Marrow Transplant 41:331-8. 2008
    ..AMD3100 plus G-CSF offers a new treatment to collect CD34+ cells for autologous transplant from poor mobilizers, with a high success rate...